If I liked it yesterday at $1.90, I love it even more at $1.85. This company is incredibly undervalued at the moment. I'm having a hard time actually believing it's under $4.00, let alone under $2.00. Watch this stock soar once the phamaceutical merger is completed. We'll be looking at these prices in our rear view mirrors.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.